Connect Biopharma Holdings Ltd. (CNTB)
0.8022
-0.03
(-3.97%)
USD |
NASDAQ |
Oct 30, 16:00
0.80
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Gross Profit Margin (Quarterly) : 0.00% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00% |
| March 31, 2026 | 2.96% |
| December 31, 2025 |
| Date | Value |
|---|---|
| September 30, 2025 | 0.00% |
| June 30, 2025 | -257.1% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -- |
| Vaxcyte, Inc. | -- |
| Foghorn Therapeutics, Inc. | 98.76% |
| Caribou Biosciences, Inc. | 58.31% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -144.8% |
| Return on Assets | -111.4% |
| Return on Invested Capital | -142.7% |
| Profit Margin (Quarterly) | -624.4% |
| Operating Margin (Quarterly) | -636.0% |
| Return on Net Operating Assets | -635.7% |